Generics 239

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Clindamycin manufacturers

239 products found

Filters

239 products found

clindamycin

Capsules 150 mg, 300 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
FDA, EU GMP
Unavailable markets
Germany , Poland , United Kingdom , Vietnam
Available for
Distribution only
Comments
Ref. Dalacin
Manufacturer #269
A pharmaceutical manufacturer based in the EU that is active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

clindamycin

Capsules 75 mg, 150 mg, 300 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Ireland , Sweden , United Kingdom
Manufacturer #20938
In the year the 2000s, it became an independent generic pharmaceutical company. It is one of the few generic pharmaceutical firms dedicated to research with the express goal of providing high-quality, low-cost healthcare to people all around the world. It all began with the goal of developing drugs to prevent, diagnose, treat, and cure diseases.

Manufacturer usually replies in 5 days

clindamycin

Cutaneous gel 1%

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17545
It is situated in Europe Province and was founded in the 1900s. It has its production, control, and development facilities. They develop medicinal specialties for cutaneous use based on metronidazole, and the addition of antibiotics, cortisone, and retinoids to their pharmaceutical list has enabled them to establish a leadership position in the Italian dermatological landscape.

Manufacturer usually replies in 4 days

clindamycin

Vials, injection 150 mg/ml - 2 ml, 4 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #419

Manufacturer usually replies in 3 days

clindamycin

Capsules 150 mg, 300 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Jordan
Registered in
Ireland
Comments
Ref: Dalacin ®
Manufacturer #337
A pharmaceutical manufacturer based in the EU that has been active in 90+ countries selling its products in the EU, Africa, North America, Middle East, and Asia for 30+ years. Key production lines are Rx and OTC. Main therapeutic areas include diabetes, CNS, and dermatology. The company's production lines are GMP-compliant. The company possesses branches in the Middle East and Asia.

Manufacturer usually replies in 5 days

clindamycin

Capsules 150 mg, 300 mg, 600 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Comments
Pack size: 16 capsules (blister strips of 8) for 150 mg & 300 mg, 12 capsules or 30 capsules (blister strips of 6) for 600 mg
Manufacturer #12923
It is the successor of one of the largest pharmaceutical manufacturers in southeast Europe. To date, it has been present over 60 years of experience in the development, production, and sale of generic drugs for human and veterinary use. It has a pharmaceutical plant with facilities for the production of the following dosage forms: capsules and tablets, liquid sterile and dry injection forms, semi-solid forms, creams, and ointments for skin and eye use. The plant has the necessary production licenses and certificates of GMP for all productions.

Manufacturer usually replies in 9 days

clindamycin + benzoyl peroxide

Cutaneous gel 10 mg + 50 mg/g, 10 mg + 30 mg/g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #12923
It is the successor of one of the largest pharmaceutical manufacturers in southeast Europe. To date, it has been present over 60 years of experience in the development, production, and sale of generic drugs for human and veterinary use. It has a pharmaceutical plant with facilities for the production of the following dosage forms: capsules and tablets, liquid sterile and dry injection forms, semi-solid forms, creams, and ointments for skin and eye use. The plant has the necessary production licenses and certificates of GMP for all productions.

Manufacturer usually replies in 9 days

clindamycin

Cutaneous solution 10 mg/g - 30 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #12923
It is the successor of one of the largest pharmaceutical manufacturers in southeast Europe. To date, it has been present over 60 years of experience in the development, production, and sale of generic drugs for human and veterinary use. It has a pharmaceutical plant with facilities for the production of the following dosage forms: capsules and tablets, liquid sterile and dry injection forms, semi-solid forms, creams, and ointments for skin and eye use. The plant has the necessary production licenses and certificates of GMP for all productions.

Manufacturer usually replies in 9 days

clindamycin

Vaginal cream 20 mg/g - 40 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #12923
It is the successor of one of the largest pharmaceutical manufacturers in southeast Europe. To date, it has been present over 60 years of experience in the development, production, and sale of generic drugs for human and veterinary use. It has a pharmaceutical plant with facilities for the production of the following dosage forms: capsules and tablets, liquid sterile and dry injection forms, semi-solid forms, creams, and ointments for skin and eye use. The plant has the necessary production licenses and certificates of GMP for all productions.

Manufacturer usually replies in 9 days

clindamycin

Vaginal capsules 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Romania , Vietnam , Poland
Manufacturer #13684
A pharmaceutical manufacturer based in the EU that has been active in Europe, CIS, Asia, Africa, and MENA for 20+ years. The main therapeutic areas include dermatology, ophthalmology, and gynecology. The company's production lines are GMP-compliant.

Manufacturer usually replies in 8 days

clindamycin + tretinoin

Cutaneous gel 1+0,025% w/w

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #13684
A pharmaceutical manufacturer based in the EU that has been active in Europe, CIS, Asia, Africa, and MENA for 20+ years. The main therapeutic areas include dermatology, ophthalmology, and gynecology. The company's production lines are GMP-compliant.

Manufacturer usually replies in 8 days

clindamycin

Solution for injection 150 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Estonia , Latvia , Lithuania
Manufacturer #2346

Manufacturer usually replies in 9 days

clindamycin

Capsules 75 mg, 150 mg, 300 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Ireland
Manufacturer #15070

A pharmaceutical manufacturer based in the EU that is selling its products in EU, CIS, and Asia. Key production lines are Rx, OTC, medical devices, and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 7 days

clindamycin

Ampoules 150 mg/ml - 2 ml, 4 ml, 6 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Manufacturer #8501

A pharmaceutical manufacturer based in Europe that has been active in 10+ countries selling its products in Europe, North America, and Asia for 100+ years. The company's production lines are cGMP-compliant. The main dosage forms include injectable and oral solid. The company possesses manufacturing facilities in Europe, North America, and Asia.

Manufacturer usually replies in 5 days

clindamycin

Gel 10 mg/g - 30 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #19992
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products for 190+ years. Key production lines are Rx, OTC, medical devices, and nutraceuticals. The company's production lines are GMP-compliant. Main therapy areas include anti-infectives, dermatology, and CNS. The company products are prepared in CTD dossier format.

Manufacturer usually replies in 5 days

clindamycin

Solution for injection 600 mg/4 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
Italy
Manufacturer #15048

It offers practical and adaptable solutions for the rapid and cost-effective development of APIs and formulations. Pharmaceutical formulations might be a generic, generic plus, or wholly novel and patented. Original chemicals and medical devices are also being developed by the business.

Manufacturer usually replies in 5 days

clindamycin

Pessary 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #304

Manufacturer usually replies in 10 days

clindamycin

Tablets, film coated 600mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #16200
It is a medium-sized international pharmaceutical firm with headquarters, development, and manufacturing in Europe with a corporate history spanning more than 65 years. The mission statement is entirely focused on providing high-quality medicines to clients promptly. Our continued success is built on qualified employees, cutting-edge production facilities and processes, as well as an appreciative and performance-enhancing corporate culture.

Manufacturer usually replies in 13 days

clindamycin

Cutaneous solution 1%

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
Canada, FDA
Unavailable markets
United States
Manufacturer #12195

Manufacturer usually replies in 9 days

clindamycin

Capsules 75 mg, 150 mg, 300 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
FDA, EU GMP, United Kingdom
Comments
All of the Products are approved by SRA and open for partnership in the US
Manufacturer #21891

Manufacturer usually replies in 5 days

Want to view all 239 products? Create your free account today!

Clindamycin Manufactureres

Clindamycin is an antibiotic that is used to treat bacterial infections such as bone, joint, and pelvic inflammatory disease, as well as various infections of the ear, nose, and throat, and endocarditis. Acne, tooth infections, skin and soft tissue infections, and peritonitis can all be treated with it. Clindamycin is used to treat infections caused by susceptible aerobic bacteria in patients who are allergic to penicillins. Clindamycin phosphate is also used to treat mild to moderate acne and some cases of methicillin-resistant Staphylococcus aureus when applied topically. Clindacin, Cleocin HCl, Evoclin,Dalacin, and Lincocin are all brands of clindamycin. Clindamycin was initially isolated from lincomycin, a naturally occurring antibiotic discovered in an Alaskan plant, in 1966. It's a generic medicine that's on the World Health Organization's Essential Medicines List. Clindamycin has a bacteriostatic action, which means it slows or stops germs from multiplying. Clindamycin, like antibiotics, acts by blocking bacterial protein synthesis and thereby preventing bacterial growth. It also has a bacteriostatic effect, which means it prevents germs from multiplying but does not kill them.Clindamycin inhibits early chain elongation by attaching to the 50s ribosomal subunit of bacteria and affecting protein synthesis in the process by interfering with the transpeptidation step. Nausea, diarrhea, redness, and soreness at the injection site are all common side effects of Clindamycin use. Topical clindamycin and benzoyl peroxide combination for long-term acne therapy perform similarly to salicylic acid plus benzoyl peroxide.

Price of Clindamycin

The wholesale cost in the poor world is US$0.06 to US$0.12 for each tablet, whereas the same medicine costs roughly $2.70 per dose in the United States, with an average price of $95.99 for 30 Capsules of 300mg each of the generic brands.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection ofClindamycin offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for Clindamycin manufacturers and Clindamycin suppliers that you are looking for. These also enable you to check the dossier status of Clindamycin, and the GMP approvals of the different variants of Clindamycin. Also, each manufacturer or supplier product description contains essential information about Clindamycin including clinical data, stability zones, countries where Clindamycin is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Clindamycin offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that Clindamycin manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Clindamycin manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.